Evidence Hub

Case Report: Refractory hypokalemia as a clinical manifestation of Crooke's cell adenoma

Kattah L, Bustamante L, Sanabria D, Salazar J

Frontiers in medicine, 2025

1 citation

Abstract

Crooke cell adenomas (CCA) are a rare and aggressive subtype of corticotrope tumors, with a prevalence of less than 1% pituitary adenomas, commonly manifest as Cushing's syndrome. We present the case of a 62-year-old male with progressive lower limb oedema, hypertension, and severe refractory hypokalemia. In this case, severe hypercortisolism was identified with the presence of a pituitary microadenoma of 9×6 mm and adrenal bilateral hyperplasia. Ectopic hypercortisolism was discarded after further evaluation. The patient was taken to a transsphenoidal endoscopic resection with complete resolution of symptoms. Histopathological and microscopic studies revealed findings consistent with Crooke cells compatible with Crooke cell adenoma. This tumor subtype exhibits a heterogeneous clinical presentation and is infrequently reported in the literature. Consequently, it represents an unpredictable clinical entity with a variable medical course.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free